“…products offered by Nutronics Labs, are free of any banned substance and are safe for athletes to use.
(PRWEB) May 09, 2012
According to court documents, the company alleges to have lost millions of dollars in sales because of "false, misleading and malicious" statements by the MLB in August regarding the IGF-1 product. The league warned its players that they could test positive for the banned steroid methyltestosterone after using the product even though it is not an ingredient. Nutronics Labs feels that the MLB should have tested their product before making any type of statement.
The main ingredient, IGF-1, is not banned by the league, but CEO Dr. Ricardo Lentini feels that the letter was the equivalent of a ban and caused both players and organizations to stop ordering the product. In response, Dr. Lentini wrote a letter to the MLB where he applauded the commissioner Bud Selig for taking precaution for his athletes, but reaffirmed that Nutronics Labs products were completely free of methyltestosterone, steroids or any other contaminates.
In the letter, Dr. Lentini states that “…products offered by Nutronics Labs, are free of any banned substance and are safe for athletes to use. We will submit an application to NSF's Certified for Sport® Program with the expectation that their testing will result in certification of our products for use by athletes.”
Nutronics Labs has been operating for over 15 years and was the very first company to bring IGF-1 from deer antler velvet to the United States. The company holds the world rights to the purest deer antler extract from New Zealand and was the first to introduce the product in a liposome spray.
The company’s product is endorsed by both the Sierra Integrative Medical Center; which specializes in chronic degenerative, autoimmune, and infectious diseases; and The National Gym Association, whose founder trained such stars as Lou Ferrigno, Arnold Schwarzenegger and Al Pacino.
For a copy of the lawsuit (Case Number: 12-12381, 17th Judicial Circuit In And For Broward County, Florida) or request an interview with CEO Dr. Ricardo Lentini:
Dr. Ricardo Lentini Ph.D.